|
Name |
2-Chloro-3,7-dihydroxy-9-methoxy-1-methyl-6H-dibenzo[b,d]pyran-6-one
|
Molecular Formula | C15H11ClO5 | |
IUPAC Name* |
2-chloro-3,7-dihydroxy-9-methoxy-1-methylbenzo[c]chromen-6-one
|
|
SMILES |
CC1=C(C(=CC2=C1C3=C(C(=CC(=C3)OC)O)C(=O)O2)O)Cl
|
|
InChI |
InChI=1S/C15H11ClO5/c1-6-12-8-3-7(20-2)4-9(17)13(8)15(19)21-11(12)5-10(18)14(6)16/h3-5,17-18H,1-2H3
|
|
InChIKey |
WMOJBLDBGQOTOS-UHFFFAOYSA-N
|
|
Synonyms |
2-Chloro-3,7-dihydroxy-9-methoxy-1-methyl-6H-dibenzo[b,d]pyran-6-one; palmariol B; CHEMBL3944011; CHEBI:141334; 2-chloro-3,7-dihydroxy-9-methoxy-1-methyl-6H-benzo[c]chromen-6-one
|
|
CAS | NA | |
PubChem CID | 46833962 | |
ChEMBL ID | CHEMBL3944011 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 306.7 | ALogp: | 3.8 |
HBD: | 2 | HBA: | 5 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 76.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 21 | QED Weighted: | 0.523 |
Caco-2 Permeability: | -4.952 | MDCK Permeability: | 0.00001200 |
Pgp-inhibitor: | 0.005 | Pgp-substrate: | 0.235 |
Human Intestinal Absorption (HIA): | 0.034 | 20% Bioavailability (F20%): | 0.008 |
30% Bioavailability (F30%): | 0.853 |
Blood-Brain-Barrier Penetration (BBB): | 0.012 | Plasma Protein Binding (PPB): | 97.56% |
Volume Distribution (VD): | 0.524 | Fu: | 4.83% |
CYP1A2-inhibitor: | 0.975 | CYP1A2-substrate: | 0.916 |
CYP2C19-inhibitor: | 0.575 | CYP2C19-substrate: | 0.09 |
CYP2C9-inhibitor: | 0.751 | CYP2C9-substrate: | 0.941 |
CYP2D6-inhibitor: | 0.693 | CYP2D6-substrate: | 0.71 |
CYP3A4-inhibitor: | 0.294 | CYP3A4-substrate: | 0.109 |
Clearance (CL): | 4.89 | Half-life (T1/2): | 0.415 |
hERG Blockers: | 0.02 | Human Hepatotoxicity (H-HT): | 0.18 |
Drug-inuced Liver Injury (DILI): | 0.971 | AMES Toxicity: | 0.369 |
Rat Oral Acute Toxicity: | 0.064 | Maximum Recommended Daily Dose: | 0.935 |
Skin Sensitization: | 0.864 | Carcinogencity: | 0.042 |
Eye Corrosion: | 0.607 | Eye Irritation: | 0.973 |
Respiratory Toxicity: | 0.519 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003471 | 0.762 | D06GCK | 0.370 | ||||
ENC003509 | 0.727 | D0K8KX | 0.345 | ||||
ENC001653 | 0.697 | D04AIT | 0.337 | ||||
ENC005808 | 0.697 | D07MGA | 0.297 | ||||
ENC005191 | 0.697 | D0FA2O | 0.284 | ||||
ENC004846 | 0.697 | D0G4KG | 0.279 | ||||
ENC003472 | 0.653 | D0R1RS | 0.248 | ||||
ENC002516 | 0.652 | D02TJS | 0.243 | ||||
ENC002609 | 0.623 | D0W7JZ | 0.233 | ||||
ENC005360 | 0.623 | D0G5UB | 0.232 |